Dasatinib Completed Phase 1 Trials for Fallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00672295PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer